ÂÜÀòÂÒÂ×

Andrew Davis is an experienced investment banking analyst currently working at Back Bay Life Science Advisors, focusing on life sciences M&A and strategic advisory. Previous roles include serving as an undergraduate researcher at the School of Biomedical Engineering at UBC, where a thesis was conducted in regenerative medicine and tissue engineering in Dr. Fabio Rossi’s lab, and as an investment banking summer analyst at Gravitas Securities Inc. Andrew also gained experience as a corporate development analyst for GenomeMe, a biotech startup, and as a scientific market researcher at Precision NanoSystems Inc., a leader in lipid nanoparticle genomic medicines. An academic background includes a Bachelor of Science and a Master of Management from The University of British Columbia, along with a high school diploma from Sentinel Secondary School and Collingwood School.